Spinal cord injury-induced osteoporosis: pathogenesis and emerging therapies
- PMID: 22983921
- PMCID: PMC3508135
- DOI: 10.1007/s11914-012-0117-0
Spinal cord injury-induced osteoporosis: pathogenesis and emerging therapies
Abstract
Spinal cord injury causes rapid, severe osteoporosis with increased fracture risk. Mechanical unloading after paralysis results in increased osteocyte expression of sclerostin, suppressed bone formation, and indirect stimulation of bone resorption. At this time, there are no clinical guidelines to prevent bone loss after SCI, and fractures are common. More research is required to define the pathophysiology and epidemiology of SCI-induced osteoporosis. This review summarizes emerging therapeutics including anti-sclerostin antibodies, mechanical loading of the lower extremity with electrical stimulation, and mechanical stimulation via vibration therapy.
Conflict of interest statement
The authors reported no potential conflicts of interest relevant to this article.
Figures

References
-
- Szollar SM, Martin EM, Sartoris DJ, et al. Bone mineral density and indexes of bone metabolism in spinal cord injury. Am J Phys Med Rehabil. 1998;77:28–35. - PubMed
-
- Garland DE, Saucedo T, Reiser TV. The management of tibial fractures in acute spinal cord injury patients. Clin Orthop Relat Res. 1986:237–240. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical